DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00080834

Locations


United States, New Mexico
	University of New Mexico Cancer Research and Treatment Center
	Albuquerque, New Mexico, United States, 87131-5636

United States, Texas
	MD Anderson Cancer Center at University of Texas
	Houston, Texas, United States, 77030-4009

Sponsors and Collaborators

Daiichi Sankyo Inc.

Investigators


Study Chair:	Peter Cheverton, MD, ChB, MMED, RadT	Daiichi Pharmaceuticals